User: Guest  Login
Document type:
journal article 
Author(s):
Stenzl, A; Feyerabend, S; Kubler, H; Retz, M; Grullich, C; Hipp, M; Klinkhardt, U; Hong, HS; Doener, F; Koch, SD; Scholl, M; Brutlach, S; Schroeder, A; Seibel, T; Halama, N; Schonborn-Kellenberger, O; Fotin-Mleczek, M; Gnad-Vogt, U 
Title:
Results of an open label randomized phase II trial of CV9104, an mRNA-based multivalent cancer immunotherapy in patients (pts) with intermediate or high risk localized prostate cancer (PC) undergoing radical prostatectomy (RPE) 
Journal title abbreviation:
Ann Oncol 
Year:
2017 
Journal volume:
28 5 
Pages contribution:
Language:
eng 
Print-ISSN:
0923-7534 
TUM Institution:
Klinik und Poliklinik für Urologie